Print

Belgium-Based Complix NV Raises Eur 5 Million  
6/9/2010 7:27:47 AM

PeHub -- Complix NV, a Belgium-based developer of “alphabodies” for autoimmune and infectious diseases, has raised €5 million in Series A funding. Backers include Vesalius Biocapital, LRM and CRP Santé.
//-->